{"gene":"NDRG4","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2001,"finding":"NDRG4 is expressed as three mRNA isoforms (NDRG4-B, NDRG4-B(var), and NDRG4-H) generated by alternative splicing and possibly alternative promoter usage. NDRG4-B is expressed only in brain, while NDRG4-H is expressed in both brain and heart. In situ hybridization localized NDRG4 to neurons of the brain and spinal cord.","method":"Northern blot, Western blot, in situ hybridization, cDNA cloning","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Northern, Western, ISH) in single foundational characterization paper","pmids":["11352569"],"is_preprint":false},{"year":2002,"finding":"NDRG4 protein is distributed mainly in mitochondria and endoplasmic reticulum (ER) in cerebral subcellular fractions. In the ER, NDRG4 protein is membrane-associated and luminally oriented, as demonstrated by detergent solubility assays and protease susceptibility experiments. Four protein isoforms (38, 39, 41, and 45 kDa) are differentially expressed during rat brain development.","method":"Subcellular fractionation, detergent solubility assay, protease susceptibility assay, Western blot","journal":"Brain research. Developmental brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct fractionation plus orthogonal protease/detergent assays in single lab","pmids":["11978392"],"is_preprint":false},{"year":2002,"finding":"Reduction of NDRG4 protein levels by antisense transfection in PC12 cells inhibits NGF-induced neurite outgrowth and suppresses NGF-mediated AP-1 transcription factor activation. Conversely, NDRG4-overexpressing clones show enhanced AP-1 activation, linking NDRG4 levels to AP-1 signaling downstream of NGF.","method":"Antisense stable transfection, neurite length measurement, reporter assay (AP-1 activation), NGF stimulation","journal":"Brain research. Developmental brain research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — loss-of-function with defined phenotype and signaling readout, single lab","pmids":["11978393"],"is_preprint":false},{"year":2006,"finding":"PC12 cells stably overexpressing Ndrg4 show enhanced NGF-induced phosphorylation of MEK and ERK, but attenuated phosphorylation of the nuclear ERK target Elk-1. The suppression of Elk-1 activation by Ndrg4 is abolished by colchicine (microtubule depolymerization) but not cytochalasin D (actin depolymerization), implicating microtubules in Ndrg4-mediated uncoupling of ERK from Elk-1.","method":"Stable overexpression in PC12 cells, phospho-Western blot, reporter assay (Elk-1/SRE), pharmacological inhibition (colchicine, cytochalasin D)","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (phospho-WB, reporter assay, pharmacological dissection), single lab","pmids":["16408304"],"is_preprint":false},{"year":2008,"finding":"Ndrg4 knockdown in zebrafish embryos causes reduced cardiomyocyte proliferation, hypoplastic hearts, abnormal heart looping, and altered expression of versican and bmp4 in the atrioventricular canal. Ndrg4 expression is positively regulated by tbx5 (loss of tbx5 decreases ndrg4; gain of tbx5 via tbx20 knockdown increases ndrg4), placing ndrg4 downstream of tbx5 in cardiac development.","method":"Morpholino knockdown in zebrafish, in situ hybridization, genetic epistasis (tbx5/tbx20 mutants), histology","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — morpholino knockdown with defined phenotype, epistasis, multiple orthogonal readouts in single rigorous study","pmids":["18407257"],"is_preprint":false},{"year":2009,"finding":"NDRG4 knockdown in GBM cells causes G1 cell cycle arrest (associated with decreased cyclin D1 and increased p27Kip1) followed by apoptosis (associated with decreased XIAP and survivin), and reduces tumorigenic capacity in intracranial xenograft models. NDRG4 overexpression has no effect on cell viability.","method":"siRNA knockdown, flow cytometry (cell cycle), Western blot, intracranial xenograft assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined molecular phenotype (cyclin D1, p27, XIAP, survivin) and in vivo validation, single lab","pmids":["19592488"],"is_preprint":false},{"year":2009,"finding":"NDRG4 overexpression in colorectal cancer cell lines suppresses colony formation, cell proliferation, and invasion, establishing a tumor suppressive function. NDRG4 promoter is methylated in ~86% of colorectal cancers compared with ~4% of noncancerous colon mucosa, and methylation correlates with reduced mRNA and protein expression.","method":"Stable transfection/overexpression, colony formation assay, cell proliferation assay, invasion assay, methylation-specific PCR, bisulfite sequencing, RT-PCR, immunohistochemistry","journal":"Journal of the National Cancer Institute","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal functional assays plus epigenetic mechanism in two independent clinical series","pmids":["19535783"],"is_preprint":false},{"year":2011,"finding":"NDRG4-deficient mice show decreased brain BDNF protein levels (with normal GDNF, NGF, NT-3, TGF-β1), impaired spatial learning and memory, and greater brain infarct sizes after focal ischemia, establishing that NDRG4 maintains intracerebral BDNF levels and confers resistance to ischemic neuronal death.","method":"Knockout mouse model, immunochemical analysis, Morris water maze, focal ischemia (MCAO) model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple defined molecular and behavioral phenotypes and selective BDNF reduction validated by protein analysis","pmids":["21636852"],"is_preprint":false},{"year":2012,"finding":"NDRG4 knockdown in meningioma cell lines causes reduced cell survival, DNA fragmentation, and G2-M cell cycle arrest, as well as decreased cellular invasion and migration. Conditioned media from NDRG4-depleted meningioma cells abrogates capillary tube formation, proliferation, and invasion of brain endothelial cells, indicating a paracrine role in angiogenesis.","method":"siRNA knockdown, spheroid/wound healing/Boyden chamber invasion assays, 3D invasion assay, endothelial tube formation assay with conditioned media","journal":"Integrative biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays with defined phenotypes, single lab","pmids":["22869042"],"is_preprint":false},{"year":2013,"finding":"NDRG4 physically interacts with Bves (blood vessel epicardial substance). This Bves/NDRG4 interaction is required for trafficking of internalized fibronectin through the autocrine ECM deposition recycling pathway and for fusion of recycling endosomes with the basal cell surface, which is necessary for directional epicardial cell movement.","method":"Protein-protein interaction (novel interaction), fibronectin recycling assay, TIRF microscopy, directional migration assay, functional disruption of Bves/NDRG4 interaction","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — novel protein-protein interaction mechanistically linked to vesicle trafficking and directional migration via multiple orthogonal methods including live-cell TIRF microscopy","pmids":["24048452"],"is_preprint":false},{"year":2015,"finding":"NDRG4 silencing in meningioma cells induces apoptosis via p53-mediated mitochondrial pathway: p53 is upregulated and phosphorylated at Ser15, BAX is activated, Bcl-2/Bcl-xL are downregulated, cytochrome c is released, and caspases are executed. Immunoprecipitation confirmed direct binding of NDRG4 to p53. A p53 phosphorylation inhibitor (PFT-α) protects against NDRG4-depletion-induced apoptosis.","method":"siRNA knockdown, Annexin-V flow cytometry, Western blot, mitochondrial membrane potential assay (JC-1), immunoprecipitation, immunofluorescence, pharmacological inhibition (PFT-α)","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP binding demonstrated plus multiple apoptosis pathway readouts, single lab","pmids":["26053091"],"is_preprint":false},{"year":2016,"finding":"In zebrafish, ndrg4 functions cell-autonomously within neurons (established by chimeric larvae analysis) to regulate sodium channel clustering at nodes of Ranvier. Loss of ndrg4 sharply decreases expression of snap25 and nsf, implicating ndrg4 in control of vesicle exocytosis via the t-SNARE/NSF machinery.","method":"Zebrafish ndrg4 mutants, chimeric larvae analysis, in situ hybridization, immunofluorescence, molecular analysis of snap25/nsf expression","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-autonomous function established by chimeric analysis, mechanistic pathway identified via molecular markers, published in peer-reviewed genetics journal","pmids":["27902705"],"is_preprint":false},{"year":2016,"finding":"NDRG4 is expressed exclusively in neurons (not glia) throughout the body including the enteric nervous system, colocalizing with HuC/D (pan-neuronal marker) but not GFAP (enteric glial marker), as established by immunohistochemistry, Western blot, in situ mRNA hybridization, and confocal immunofluorescence on wild-type vs. knockout mouse tissues.","method":"Immunohistochemistry, Western blot, in situ mRNA hybridization, immunofluorescence/confocal microscopy, NDRG4 knockout mouse validation","journal":"Neurogastroenterology and motility","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods with genetic control (KO mice), cell-type specificity rigorously established","pmids":["28524415"],"is_preprint":false},{"year":2017,"finding":"NDRG4 promotes myogenic differentiation by binding to CTMP (carboxyl-terminal modulator protein), thereby reducing the CTMP-Akt interaction, increasing Akt phosphorylation, and activating CREB, which drives expression of MyoD, myogenin, and myosin heavy chain.","method":"Gain/loss-of-function in C2C12 cells, co-immunoprecipitation (NDRG4-CTMP interaction), Western blot (p-Akt, p-CREB), myotube formation assay, qRT-PCR","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP interaction plus downstream pathway readouts and functional phenotype, single lab","pmids":["29254199"],"is_preprint":false},{"year":2018,"finding":"NDRG4 interacts with p53 (confirmed by co-IP and immunofluorescence) and inhibits p53 expression and p53-mediated mitochondrial apoptosis signaling in cerebral ischemia/reperfusion injury. NDRG4 overexpression decreases infarct size; conversely, p53 in turn inhibits NDRG4 expression after I/R injury, creating a regulatory feedback.","method":"MCAO rat model, adenoviral overexpression, co-immunoprecipitation, immunofluorescence, Western blot, infarct size measurement","journal":"Brain research bulletin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein interaction shown by Co-IP, functional consequence demonstrated in vivo, single lab","pmids":["30593880"],"is_preprint":false},{"year":2019,"finding":"Epigenetic silencing of NDRG4 via promoter hypermethylation in breast cancer cells promotes integrin signaling: NDRG4 downregulation assembles β1-integrins into large punctate clusters at the leading edge of tumor cells, causing decreased adhesion to fibronectin and increased adhesion and migration towards vitronectin, facilitating lymph node metastasis.","method":"Stable knockdown, integrin clustering assay (immunofluorescence), adhesion/migration assays to fibronectin and vitronectin, methylation analysis, clinical cohort correlation","journal":"NPJ breast cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mechanism (integrin reorganization) linked to loss-of-function with multiple assays, single lab","pmids":["30963110"],"is_preprint":false},{"year":2020,"finding":"miR-218-5p directly targets NDRG4 (validated by luciferase reporter assay). In OGD/R-injured PC12 cells, miR-218-5p inhibition upregulates NDRG4 and reduces inflammatory cytokines, oxidative stress, and apoptosis; NDRG4 silencing abolishes these protective effects, placing NDRG4 as a functional downstream target of miR-218-5p.","method":"Luciferase reporter assay, miRNA inhibitor transfection, siRNA knockdown, flow cytometry, Western blot, OGD/R model","journal":"Medical science monitor","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct miRNA-target interaction validated by reporter assay with epistasis rescue experiment, single lab","pmids":["32048632"],"is_preprint":false},{"year":2020,"finding":"miR-433 directly targets NDRG4 (validated by dual-luciferase reporter assay and Western blot). miR-433 inhibition activates the PI3K/Akt pathway and protects against hypoxia/reoxygenation injury in H9c2 cardiomyocytes; NDRG4 silencing reverses these protective effects, placing NDRG4 as an effector of miR-433 in the PI3K/Akt pathway during myocardial I/R injury.","method":"Dual-luciferase reporter assay, Western blot, miRNA mimic/inhibitor transfection, siRNA knockdown, flow cytometry, in vivo rat IR model with antagomiR","journal":"Shock","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct miRNA-target validated by reporter assay, epistasis by NDRG4 knockdown rescue, in vivo confirmation, single lab","pmids":["32187107"],"is_preprint":false},{"year":2021,"finding":"Loss of Ndrg4 in enteric neurons is associated with enlarged intestinal adenoma development. Ndrg4-/- enteric nervous system cell secretome, enriched for Nidogen-1 (Nid1) and Fibulin-2 (Fbln2), boosts organoid growth and enhances CRC cell migration, linking NDRG4 in enteric neurons to paracrine regulation of colorectal carcinogenesis.","method":"Ndrg4 knockout mouse CRC models, indirect co-culture of ENS cells and intestinal organoids, quantitative proteomics of secretome, migration assay, in vivo adenoma models","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — combined in vivo, in vitro, and quantitative proteomics with mechanistic identification of secreted effectors (Nid1, Fbln2), rigorous use of KO models","pmids":["33890711"],"is_preprint":false},{"year":2021,"finding":"NDRG4 sensitizes colorectal cancer cells to 5-FU by upregulating DDIT3 (CHOP) expression. NDRG4 inhibits PI3K/AKT and ERK signaling, promotes 5-FU-induced apoptosis, and this proapoptotic effect is dependent on DDIT3.","method":"Stable overexpression, cell proliferation assay, Western blot (PI3K/AKT, ERK), DDIT3 knockdown rescue experiment, apoptosis assay","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway inhibition shown plus epistasis via DDIT3 knockdown, single lab","pmids":["34594423"],"is_preprint":false},{"year":2021,"finding":"A missense variant p.T256M in NDRG4 impairs proliferation of human cardiac myocytes (hCM) and causes G1 and G2 cell cycle arrest with increased p27 and caspase-9 expression, providing evidence that this variant is pathogenic in pulmonary atresia with ventricular septal defect and tetralogy of Fallot.","method":"Patient exome sequencing, functional assay in hCM (proliferation, cell cycle analysis, Western blot for p27 and caspase-9)","journal":"FEBS open bio","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — variant functional characterization in human cells with defined molecular readouts, single study","pmids":["33211401"],"is_preprint":false},{"year":2020,"finding":"NDRG4 overexpression in esophageal adenocarcinoma cells downregulates Cyclin D1, CDK4, and CDK6 protein levels and inhibits tumor cell growth in 2D and 3D organotypic culture models, implicating NDRG4 in cell cycle regulation through CDK/Cyclin pathways.","method":"Stable overexpression, Western blot (Cyclin D1, CDK4, CDK6), 2D/3D organotypic growth assay, EdU proliferation assay","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays with defined molecular targets, single lab","pmids":["32927604"],"is_preprint":false},{"year":2020,"finding":"NDRG4 overexpression in pancreatic ductal adenocarcinoma cells attenuates mitochondrial function: reduces ATP production, decreases mitochondrial membrane potential, and increases mitochondrial fragmentation. NDRG4 knockdown in normal pancreatic cells produces opposite effects, establishing a direct role for NDRG4 in mitochondrial regulation.","method":"Stable overexpression and knockdown, ATP production assay, mitochondrial membrane potential assay, mitochondrial morphology analysis","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain and loss of function with multiple mitochondrial readouts, single lab","pmids":["33298240"],"is_preprint":false}],"current_model":"NDRG4 is a neuron-specific (and cardiomyocyte-expressed) member of the NDRG family that localizes to mitochondria and ER; it acts downstream of TBX5 during cardiac development to support cardiomyocyte proliferation, functions within neurons to regulate vesicle exocytosis (via snap25/NSF) and sodium channel clustering at nodes of Ranvier, maintains brain BDNF levels, promotes neurite outgrowth and NGF-MEK/ERK signaling (while attenuating nuclear Elk-1 activation via microtubules), physically interacts with CTMP to activate the Akt/CREB axis for myogenesis, physically interacts with p53 to suppress p53-mediated mitochondrial apoptosis, physically interacts with Bves to direct fibronectin recycling endosome fusion for directional epithelial migration, modulates integrin clustering and cell adhesion to regulate metastatic behavior, and is epigenetically silenced by promoter hypermethylation in multiple cancers where its loss promotes tumor cell proliferation, invasion, and—in the enteric nervous system—paracrine secretion of Nid1/Fbln2 that drives colorectal carcinogenesis."},"narrative":{"mechanistic_narrative":"NDRG4 is a neuron- and cardiomyocyte-enriched cytoplasmic protein that couples intracellular signaling and vesicle trafficking to control cell proliferation, differentiation, migration, and survival across neural, cardiac, and epithelial tissues [PMID:18407257, PMID:21636852, PMID:27902705]. In neurons it functions cell-autonomously to support sodium channel clustering at nodes of Ranvier and to maintain expression of the exocytic machinery snap25 and nsf, and is required for normal NGF-induced neurite outgrowth and downstream AP-1 and MEK/ERK signaling, while uncoupling ERK from nuclear Elk-1 activation in a microtubule-dependent manner [PMID:27902705, PMID:11978393, PMID:16408304]. NDRG4-deficient mice show selectively reduced brain BDNF, impaired spatial learning, and enlarged ischemic infarcts, establishing a neuroprotective role [PMID:21636852]. During cardiac development NDRG4 acts downstream of tbx5 to drive cardiomyocyte proliferation and proper heart morphogenesis [PMID:18407257]. NDRG4 executes its cellular roles through defined physical partners: it binds Bves to direct fibronectin recycling-endosome fusion required for directional epithelial migration [PMID:24048452], binds CTMP to relieve CTMP inhibition of Akt and thereby activate CREB-driven myogenic differentiation [PMID:29254199], and binds p53 to restrain p53-mediated mitochondrial apoptosis [PMID:26053091, PMID:30593880]. NDRG4 is epigenetically silenced by promoter hypermethylation in colorectal, breast, and other cancers, where it normally suppresses proliferation, invasion, and metastasis—acting through cell-cycle control (cyclin D1/p27, CDK4/6), integrin clustering and adhesion, and, in the enteric nervous system, by limiting paracrine secretion of Nid1/Fbln2 that drives colorectal carcinogenesis [PMID:19535783, PMID:30963110, PMID:32927604, PMID:33890711]. A pathogenic missense variant (p.T256M) impairing cardiomyocyte proliferation links NDRG4 to pulmonary atresia with ventricular septal defect and tetralogy of Fallot [PMID:33211401].","teleology":[{"year":2001,"claim":"Establishing where NDRG4 is expressed was the prerequisite for any functional model; isoform mapping showed brain- and heart-restricted expression localized to neurons.","evidence":"Northern/Western blot, in situ hybridization and cDNA cloning of three splice isoforms","pmids":["11352569"],"confidence":"Medium","gaps":["Isoform-specific functions not resolved","No subcellular localization defined at this stage"]},{"year":2002,"claim":"Subcellular fractionation answered where NDRG4 acts within the cell, placing it at mitochondria and as a membrane-associated, luminally oriented ER protein.","evidence":"Subcellular fractionation with detergent solubility and protease susceptibility assays in rat brain","pmids":["11978392"],"confidence":"Medium","gaps":["Membrane topology determinants unknown","Functional consequence of ER/mitochondrial localization not tested here"]},{"year":2002,"claim":"Loss- and gain-of-function in PC12 cells linked NDRG4 levels to NGF-driven neurite outgrowth and AP-1 activation, giving it a role in neuronal differentiation signaling.","evidence":"Antisense and overexpression PC12 clones, neurite measurement, AP-1 reporter assay","pmids":["11978393"],"confidence":"Medium","gaps":["Molecular mechanism connecting NDRG4 to AP-1 not defined","No direct binding partner identified"]},{"year":2006,"claim":"Pharmacological dissection refined the signaling role, showing NDRG4 enhances NGF-induced MEK/ERK phosphorylation yet attenuates nuclear Elk-1 activation via microtubules.","evidence":"Stable overexpression in PC12 cells, phospho-Western, Elk-1/SRE reporter, colchicine vs cytochalasin D","pmids":["16408304"],"confidence":"Medium","gaps":["Mechanism of microtubule involvement unresolved","No direct ERK-pathway interactor shown"]},{"year":2008,"claim":"Zebrafish knockdown placed NDRG4 in cardiac development downstream of tbx5, answering whether its heart expression is functionally required for cardiomyocyte proliferation.","evidence":"Morpholino knockdown, in situ hybridization, tbx5/tbx20 genetic epistasis, histology","pmids":["18407257"],"confidence":"High","gaps":["Direct transcriptional link from tbx5 to ndrg4 not shown","Effector mediating proliferation downstream of ndrg4 unknown"]},{"year":2009,"claim":"Parallel cancer studies established opposing context-dependent roles: NDRG4 is required for GBM survival but is a methylation-silenced tumor suppressor in colorectal cancer.","evidence":"siRNA knockdown with cell-cycle/apoptosis readouts and xenografts (GBM); overexpression assays plus methylation-specific PCR in CRC cohorts","pmids":["19592488","19535783"],"confidence":"High","gaps":["Basis of tissue-specific oncogenic vs suppressive role unexplained","Direct targets of cell-cycle regulation not identified"]},{"year":2011,"claim":"The knockout mouse answered NDRG4's organismal neural function, showing it maintains brain BDNF, supports learning and memory, and protects against ischemic injury.","evidence":"Ndrg4 knockout mice, immunochemical neurotrophin profiling, Morris water maze, MCAO ischemia model","pmids":["21636852"],"confidence":"High","gaps":["Mechanism by which NDRG4 maintains BDNF unresolved","Cell type responsible for protection not pinpointed"]},{"year":2013,"claim":"Identification of the Bves interaction provided the first direct molecular mechanism, linking NDRG4 to fibronectin recycling-endosome fusion and directional migration.","evidence":"Protein interaction mapping, fibronectin recycling assay, TIRF microscopy, directional migration assay","pmids":["24048452"],"confidence":"High","gaps":["Structural basis of Bves/NDRG4 interaction unknown","Generality across cell types untested"]},{"year":2015,"claim":"Co-IP demonstrated NDRG4 binds p53 and restrains p53-mediated mitochondrial apoptosis, explaining the pro-survival side of its cancer phenotype.","evidence":"siRNA knockdown, Annexin-V/JC-1 assays, immunoprecipitation, PFT-α inhibition in meningioma cells","pmids":["26053091"],"confidence":"Medium","gaps":["Direct binding interface not mapped","Single cell-type context"]},{"year":2016,"claim":"Cell-autonomous zebrafish analysis defined a neuronal mechanism: NDRG4 controls node-of-Ranvier sodium channel clustering and the snap25/nsf exocytic machinery.","evidence":"ndrg4 mutant and chimeric larvae, in situ hybridization, immunofluorescence, snap25/nsf expression analysis","pmids":["27902705"],"confidence":"High","gaps":["How NDRG4 regulates snap25/nsf transcription unknown","Direct involvement in vesicle fusion not biochemically shown"]},{"year":2016,"claim":"Rigorous cell-type mapping established that NDRG4 is exclusively neuronal, including the enteric nervous system, refining all downstream interpretation.","evidence":"Immunohistochemistry, in situ hybridization, confocal immunofluorescence with HuC/D and GFAP markers, KO mouse validation","pmids":["28524415"],"confidence":"High","gaps":["Subtype specificity within neurons not resolved"]},{"year":2017,"claim":"The CTMP interaction explained how NDRG4 activates Akt/CREB signaling to promote myogenic differentiation.","evidence":"C2C12 gain/loss-of-function, co-IP of NDRG4-CTMP, phospho-Akt/CREB Western, myotube and qRT-PCR assays","pmids":["29254199"],"confidence":"Medium","gaps":["Whether CTMP regulation operates in neural/cardiac contexts untested","Binding interface not defined"]},{"year":2020,"claim":"Cancer mechanism studies expanded NDRG4's suppressive repertoire to integrin reorganization, CDK/Cyclin control, and mitochondrial function across breast, esophageal, and pancreatic models.","evidence":"Knockdown/overexpression with integrin clustering and adhesion assays, CDK4/6/Cyclin D1 Western, mitochondrial ATP/membrane-potential/morphology assays","pmids":["30963110","32927604","33298240"],"confidence":"Medium","gaps":["Direct molecular partners for integrin and mitochondrial effects not identified","Single-lab findings per tumor type"]},{"year":2020,"claim":"miRNA studies positioned NDRG4 as a regulated downstream effector in ischemia/reperfusion injury, with miR-218-5p and miR-433 directly targeting it.","evidence":"Luciferase reporter validation, miRNA mimic/inhibitor and siRNA rescue in OGD/R PC12 and H9c2 cells, in vivo IR models","pmids":["32048632","32187107"],"confidence":"Medium","gaps":["Whether NDRG4 itself drives PI3K/Akt protection mechanistically unresolved","Physiological miRNA-NDRG4 axis in vivo not fully established"]},{"year":2021,"claim":"Combined in vivo and proteomic work showed enteric-neuronal NDRG4 loss drives colorectal carcinogenesis through paracrine secretion of Nid1/Fbln2, and a separate study linked NDRG4 to 5-FU chemosensitivity via DDIT3.","evidence":"Ndrg4 KO CRC mouse models, ENS-organoid co-culture, secretome proteomics; overexpression with DDIT3 knockdown rescue and apoptosis assays","pmids":["33890711","34594423"],"confidence":"High","gaps":["How neuronal NDRG4 loss controls Nid1/Fbln2 secretion mechanistically unknown","Receptor on tumor cells for paracrine signal not identified"]},{"year":2021,"claim":"Functional characterization of a patient missense variant provided direct evidence linking NDRG4 to congenital heart disease.","evidence":"Exome sequencing and p.T256M functional assays in human cardiac myocytes (proliferation, cell cycle, p27/caspase-9 Western)","pmids":["33211401"],"confidence":"Medium","gaps":["Single variant in limited patient set","Mechanism by which T256M impairs proliferation not resolved"]},{"year":null,"claim":"The biochemical activity of NDRG4 itself—whether it has intrinsic catalytic, scaffolding, or adaptor function that unifies its diverse interactions with Bves, CTMP, and p53—remains undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined enzymatic or biochemical activity","No structural model linking partner interactions","Mechanism unifying neuronal, cardiac, and tumor-suppressive roles unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[9,13,10]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1,22]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,18,15]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[10,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,13]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[9,11]}],"complexes":[],"partners":["BVES","CTMP","TP53"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9ULP0","full_name":"Protein NDRG4","aliases":["Brain development-related molecule 1","N-myc downstream-regulated gene 4 protein","Vascular smooth muscle cell-associated protein 8","SMAP-8"],"length_aa":352,"mass_kda":38.5,"function":"Contributes to the maintenance of intracerebral BDNF levels within the normal range, which is necessary for the preservation of spatial learning and the resistance to neuronal cell death caused by ischemic stress (By similarity). May enhance growth factor-induced ERK1 and ERK2 phosphorylation, including that induced by PDGF and FGF. May attenuate NGF-promoted ELK1 phosphorylation in a microtubule-dependent manner","subcellular_location":"Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q9ULP0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDRG4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDRG4","total_profiled":1310},"omim":[{"mim_id":"614463","title":"NMYC DOWNSTREAM-REGULATED GENE 4; NDRG4","url":"https://www.omim.org/entry/614463"},{"mim_id":"605273","title":"NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3","url":"https://www.omim.org/entry/605273"},{"mim_id":"605272","title":"NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2","url":"https://www.omim.org/entry/605272"},{"mim_id":"228550","title":"MYOFIBROMATOSIS, INFANTILE, 1; IMF1","url":"https://www.omim.org/entry/228550"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":347.4},{"tissue":"heart muscle","ntpm":326.5}],"url":"https://www.proteinatlas.org/search/NDRG4"},"hgnc":{"alias_symbol":["KIAA1180","SMAP-8"],"prev_symbol":[]},"alphafold":{"accession":"Q9ULP0","domains":[{"cath_id":"3.40.50.1820","chopping":"6-285","consensus_level":"high","plddt":94.3487,"start":6,"end":285}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9ULP0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9ULP0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9ULP0-F1-predicted_aligned_error_v6.png","plddt_mean":84.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDRG4","jax_strain_url":"https://www.jax.org/strain/search?query=NDRG4"},"sequence":{"accession":"Q9ULP0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9ULP0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9ULP0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9ULP0"}},"corpus_meta":[{"pmid":"11352569","id":"PMC_11352569","title":"Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11352569","citation_count":200,"is_preprint":false},{"pmid":"19535783","id":"PMC_19535783","title":"N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.","date":"2009","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/19535783","citation_count":178,"is_preprint":false},{"pmid":"18407257","id":"PMC_18407257","title":"Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18407257","citation_count":68,"is_preprint":false},{"pmid":"21636852","id":"PMC_21636852","title":"NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21636852","citation_count":67,"is_preprint":false},{"pmid":"25663916","id":"PMC_25663916","title":"Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/25663916","citation_count":57,"is_preprint":false},{"pmid":"25202404","id":"PMC_25202404","title":"DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/25202404","citation_count":53,"is_preprint":false},{"pmid":"19592488","id":"PMC_19592488","title":"NDRG4 is required for cell cycle progression and survival in glioblastoma cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19592488","citation_count":50,"is_preprint":false},{"pmid":"24048452","id":"PMC_24048452","title":"Bves and NDRG4 regulate directional epicardial cell migration through autocrine extracellular matrix deposition.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/24048452","citation_count":40,"is_preprint":false},{"pmid":"11978393","id":"PMC_11978393","title":"Inhibition of neurite outgrowth by reduced level of NDRG4 protein in antisense transfected PC12 cells.","date":"2002","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11978393","citation_count":40,"is_preprint":false},{"pmid":"32196834","id":"PMC_32196834","title":"TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis.","date":"2020","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32196834","citation_count":34,"is_preprint":false},{"pmid":"33890711","id":"PMC_33890711","title":"Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/33890711","citation_count":33,"is_preprint":false},{"pmid":"29142517","id":"PMC_29142517","title":"Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population?","date":"2017","source":"Intestinal research","url":"https://pubmed.ncbi.nlm.nih.gov/29142517","citation_count":33,"is_preprint":false},{"pmid":"26053091","id":"PMC_26053091","title":"NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26053091","citation_count":27,"is_preprint":false},{"pmid":"22489821","id":"PMC_22489821","title":"NDRG4 is downregulated in glioblastoma and inhibits cell proliferation.","date":"2012","source":"Omics : a journal of integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/22489821","citation_count":26,"is_preprint":false},{"pmid":"22869042","id":"PMC_22869042","title":"NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.","date":"2012","source":"Integrative biology : quantitative biosciences from nano to macro","url":"https://pubmed.ncbi.nlm.nih.gov/22869042","citation_count":24,"is_preprint":false},{"pmid":"23725756","id":"PMC_23725756","title":"NDRG3 and NDRG4, two novel tumor-related genes.","date":"2013","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/23725756","citation_count":23,"is_preprint":false},{"pmid":"30593880","id":"PMC_30593880","title":"NDRG4 protects against cerebral ischemia injury by inhibiting p53-mediated apoptosis.","date":"2018","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/30593880","citation_count":22,"is_preprint":false},{"pmid":"32048632","id":"PMC_32048632","title":"Downregulation of MiR-218-5p Protects Against Oxygen-Glucose Deprivation/Reperfusion-Induced Injuries of PC12 Cells via Upregulating N-myc Downstream Regulated Gene 4 (NDRG4).","date":"2020","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/32048632","citation_count":21,"is_preprint":false},{"pmid":"27902705","id":"PMC_27902705","title":"Neuronal Ndrg4 Is Essential for Nodes of Ranvier Organization in Zebrafish.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27902705","citation_count":20,"is_preprint":false},{"pmid":"26976975","id":"PMC_26976975","title":"NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.","date":"2016","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26976975","citation_count":18,"is_preprint":false},{"pmid":"11978392","id":"PMC_11978392","title":"Molecular characterization of NDRG4/Bdm1 protein isoforms that are differentially regulated during rat brain development.","date":"2002","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11978392","citation_count":18,"is_preprint":false},{"pmid":"16408304","id":"PMC_16408304","title":"Ndrg4 enhances NGF-induced ERK activation uncoupled with Elk-1 activation.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16408304","citation_count":18,"is_preprint":false},{"pmid":"29254199","id":"PMC_29254199","title":"NDRG4 promotes myogenesis via Akt/CREB activation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29254199","citation_count":16,"is_preprint":false},{"pmid":"30963110","id":"PMC_30963110","title":"NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.","date":"2019","source":"NPJ breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30963110","citation_count":16,"is_preprint":false},{"pmid":"29500881","id":"PMC_29500881","title":"NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.","date":"2018","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29500881","citation_count":15,"is_preprint":false},{"pmid":"31832525","id":"PMC_31832525","title":"NDRG4 prevents cerebral ischemia/reperfusion injury by inhibiting neuronal apoptosis.","date":"2019","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31832525","citation_count":15,"is_preprint":false},{"pmid":"28524415","id":"PMC_28524415","title":"NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons.","date":"2017","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/28524415","citation_count":13,"is_preprint":false},{"pmid":"32187107","id":"PMC_32187107","title":"MiR-433 Regulates Myocardial Ischemia Reperfusion Injury by Targeting NDRG4 Via the PI3K/Akt Pathway.","date":"2020","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/32187107","citation_count":13,"is_preprint":false},{"pmid":"25241110","id":"PMC_25241110","title":"Exome sequencing identifies a novel homozygous variant in NDRG4 in a family with infantile myofibromatosis.","date":"2014","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25241110","citation_count":12,"is_preprint":false},{"pmid":"27175791","id":"PMC_27175791","title":"Uterine Expression of NDRG4 Is Induced by Estrogen and Up-Regulated during Embryo Implantation Process in Mice.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27175791","citation_count":10,"is_preprint":false},{"pmid":"36374403","id":"PMC_36374403","title":"miR-23a-3p promotes the development of colon cancer by inhibiting the expression of NDRG4.","date":"2022","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/36374403","citation_count":10,"is_preprint":false},{"pmid":"26801554","id":"PMC_26801554","title":"Postnatal lethality and abnormal development of foregut and spleen in Ndrg4 mutant mice.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26801554","citation_count":9,"is_preprint":false},{"pmid":"32927604","id":"PMC_32927604","title":"N-MYC Downstream Regulated Gene 4 (NDRG4), a Frequent Downregulated Gene through DNA Hypermethylation, plays a Tumor Suppressive Role in Esophageal Adenocarcinoma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32927604","citation_count":9,"is_preprint":false},{"pmid":"14693380","id":"PMC_14693380","title":"Genomic organization, expression, and comparative analysis of noncoding region of the rat Ndrg4 gene.","date":"2004","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/14693380","citation_count":8,"is_preprint":false},{"pmid":"33298240","id":"PMC_33298240","title":"Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function.","date":"2020","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/33298240","citation_count":8,"is_preprint":false},{"pmid":"38657364","id":"PMC_38657364","title":"LC-MS based metabonomics study on protective mechanism of ESWW in cerebral ischemia via CYTC/Apaf-1/NDRG4 pathway.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38657364","citation_count":7,"is_preprint":false},{"pmid":"34594423","id":"PMC_34594423","title":"NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34594423","citation_count":5,"is_preprint":false},{"pmid":"38226561","id":"PMC_38226561","title":"Evaluating the clinical performance of SDC2/NDRG4 methylation for colorectal cancer detection.","date":"2024","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/38226561","citation_count":5,"is_preprint":false},{"pmid":"35126626","id":"PMC_35126626","title":"NDRG4 Alleviates Myocardial Infarction-Induced Apoptosis through the JAK2/STAT3 Pathway.","date":"2022","source":"Computational and mathematical methods in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35126626","citation_count":4,"is_preprint":false},{"pmid":"32166572","id":"PMC_32166572","title":"NDRG4 Alleviates Aβ1-40 Induction of SH-SY5Y Cell Injury via Activation of BDNF-Inducing Signalling Pathways.","date":"2020","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/32166572","citation_count":4,"is_preprint":false},{"pmid":"33211401","id":"PMC_33211401","title":"A loss-of-function mutation p.T256M in NDRG4 is implicated in the pathogenesis of pulmonary atresia with ventricular septal defect (PA/VSD) and tetralogy of Fallot (TOF).","date":"2021","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/33211401","citation_count":4,"is_preprint":false},{"pmid":"34564976","id":"PMC_34564976","title":"Highly sensitive fecal DNA testing of NDRG4 12b methylation is a promising marker for detection of colorectal precancerosis.","date":"2021","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34564976","citation_count":2,"is_preprint":false},{"pmid":"38094327","id":"PMC_38094327","title":"Retracted: NDRG4 Alleviates Myocardial Infarction-Induced Apoptosis through the JAK2/STAT3 Pathway.","date":"2023","source":"Computational and mathematical methods in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38094327","citation_count":0,"is_preprint":false},{"pmid":"41484166","id":"PMC_41484166","title":"NDRG4 overexpression is associated with reduced apoptosis after intracerebral hemorrhage via the PI3K/Akt/GSK3β signaling pathway.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41484166","citation_count":0,"is_preprint":false},{"pmid":"42257837","id":"PMC_42257837","title":"Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression.","date":"2026","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/42257837","citation_count":0,"is_preprint":false},{"pmid":"35707763","id":"PMC_35707763","title":"Erratum: NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression.","date":"2022","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/35707763","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.12.653623","title":"VAMP5 is a novel target for selective inhibition of gliomas with high NDRG4 expression via downregulating PLK1 and beyond","date":"2025-05-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.12.653623","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25278,"output_tokens":5940,"usd":0.082467,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14538,"output_tokens":4823,"usd":0.096632,"stage2_stop_reason":"end_turn"},"total_usd":0.179099,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"NDRG4 is expressed as three mRNA isoforms (NDRG4-B, NDRG4-B(var), and NDRG4-H) generated by alternative splicing and possibly alternative promoter usage. NDRG4-B is expressed only in brain, while NDRG4-H is expressed in both brain and heart. In situ hybridization localized NDRG4 to neurons of the brain and spinal cord.\",\n      \"method\": \"Northern blot, Western blot, in situ hybridization, cDNA cloning\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Northern, Western, ISH) in single foundational characterization paper\",\n      \"pmids\": [\"11352569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NDRG4 protein is distributed mainly in mitochondria and endoplasmic reticulum (ER) in cerebral subcellular fractions. In the ER, NDRG4 protein is membrane-associated and luminally oriented, as demonstrated by detergent solubility assays and protease susceptibility experiments. Four protein isoforms (38, 39, 41, and 45 kDa) are differentially expressed during rat brain development.\",\n      \"method\": \"Subcellular fractionation, detergent solubility assay, protease susceptibility assay, Western blot\",\n      \"journal\": \"Brain research. Developmental brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation plus orthogonal protease/detergent assays in single lab\",\n      \"pmids\": [\"11978392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Reduction of NDRG4 protein levels by antisense transfection in PC12 cells inhibits NGF-induced neurite outgrowth and suppresses NGF-mediated AP-1 transcription factor activation. Conversely, NDRG4-overexpressing clones show enhanced AP-1 activation, linking NDRG4 levels to AP-1 signaling downstream of NGF.\",\n      \"method\": \"Antisense stable transfection, neurite length measurement, reporter assay (AP-1 activation), NGF stimulation\",\n      \"journal\": \"Brain research. Developmental brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — loss-of-function with defined phenotype and signaling readout, single lab\",\n      \"pmids\": [\"11978393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PC12 cells stably overexpressing Ndrg4 show enhanced NGF-induced phosphorylation of MEK and ERK, but attenuated phosphorylation of the nuclear ERK target Elk-1. The suppression of Elk-1 activation by Ndrg4 is abolished by colchicine (microtubule depolymerization) but not cytochalasin D (actin depolymerization), implicating microtubules in Ndrg4-mediated uncoupling of ERK from Elk-1.\",\n      \"method\": \"Stable overexpression in PC12 cells, phospho-Western blot, reporter assay (Elk-1/SRE), pharmacological inhibition (colchicine, cytochalasin D)\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (phospho-WB, reporter assay, pharmacological dissection), single lab\",\n      \"pmids\": [\"16408304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ndrg4 knockdown in zebrafish embryos causes reduced cardiomyocyte proliferation, hypoplastic hearts, abnormal heart looping, and altered expression of versican and bmp4 in the atrioventricular canal. Ndrg4 expression is positively regulated by tbx5 (loss of tbx5 decreases ndrg4; gain of tbx5 via tbx20 knockdown increases ndrg4), placing ndrg4 downstream of tbx5 in cardiac development.\",\n      \"method\": \"Morpholino knockdown in zebrafish, in situ hybridization, genetic epistasis (tbx5/tbx20 mutants), histology\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — morpholino knockdown with defined phenotype, epistasis, multiple orthogonal readouts in single rigorous study\",\n      \"pmids\": [\"18407257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NDRG4 knockdown in GBM cells causes G1 cell cycle arrest (associated with decreased cyclin D1 and increased p27Kip1) followed by apoptosis (associated with decreased XIAP and survivin), and reduces tumorigenic capacity in intracranial xenograft models. NDRG4 overexpression has no effect on cell viability.\",\n      \"method\": \"siRNA knockdown, flow cytometry (cell cycle), Western blot, intracranial xenograft assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined molecular phenotype (cyclin D1, p27, XIAP, survivin) and in vivo validation, single lab\",\n      \"pmids\": [\"19592488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NDRG4 overexpression in colorectal cancer cell lines suppresses colony formation, cell proliferation, and invasion, establishing a tumor suppressive function. NDRG4 promoter is methylated in ~86% of colorectal cancers compared with ~4% of noncancerous colon mucosa, and methylation correlates with reduced mRNA and protein expression.\",\n      \"method\": \"Stable transfection/overexpression, colony formation assay, cell proliferation assay, invasion assay, methylation-specific PCR, bisulfite sequencing, RT-PCR, immunohistochemistry\",\n      \"journal\": \"Journal of the National Cancer Institute\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal functional assays plus epigenetic mechanism in two independent clinical series\",\n      \"pmids\": [\"19535783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NDRG4-deficient mice show decreased brain BDNF protein levels (with normal GDNF, NGF, NT-3, TGF-β1), impaired spatial learning and memory, and greater brain infarct sizes after focal ischemia, establishing that NDRG4 maintains intracerebral BDNF levels and confers resistance to ischemic neuronal death.\",\n      \"method\": \"Knockout mouse model, immunochemical analysis, Morris water maze, focal ischemia (MCAO) model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple defined molecular and behavioral phenotypes and selective BDNF reduction validated by protein analysis\",\n      \"pmids\": [\"21636852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NDRG4 knockdown in meningioma cell lines causes reduced cell survival, DNA fragmentation, and G2-M cell cycle arrest, as well as decreased cellular invasion and migration. Conditioned media from NDRG4-depleted meningioma cells abrogates capillary tube formation, proliferation, and invasion of brain endothelial cells, indicating a paracrine role in angiogenesis.\",\n      \"method\": \"siRNA knockdown, spheroid/wound healing/Boyden chamber invasion assays, 3D invasion assay, endothelial tube formation assay with conditioned media\",\n      \"journal\": \"Integrative biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays with defined phenotypes, single lab\",\n      \"pmids\": [\"22869042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDRG4 physically interacts with Bves (blood vessel epicardial substance). This Bves/NDRG4 interaction is required for trafficking of internalized fibronectin through the autocrine ECM deposition recycling pathway and for fusion of recycling endosomes with the basal cell surface, which is necessary for directional epicardial cell movement.\",\n      \"method\": \"Protein-protein interaction (novel interaction), fibronectin recycling assay, TIRF microscopy, directional migration assay, functional disruption of Bves/NDRG4 interaction\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — novel protein-protein interaction mechanistically linked to vesicle trafficking and directional migration via multiple orthogonal methods including live-cell TIRF microscopy\",\n      \"pmids\": [\"24048452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDRG4 silencing in meningioma cells induces apoptosis via p53-mediated mitochondrial pathway: p53 is upregulated and phosphorylated at Ser15, BAX is activated, Bcl-2/Bcl-xL are downregulated, cytochrome c is released, and caspases are executed. Immunoprecipitation confirmed direct binding of NDRG4 to p53. A p53 phosphorylation inhibitor (PFT-α) protects against NDRG4-depletion-induced apoptosis.\",\n      \"method\": \"siRNA knockdown, Annexin-V flow cytometry, Western blot, mitochondrial membrane potential assay (JC-1), immunoprecipitation, immunofluorescence, pharmacological inhibition (PFT-α)\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP binding demonstrated plus multiple apoptosis pathway readouts, single lab\",\n      \"pmids\": [\"26053091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In zebrafish, ndrg4 functions cell-autonomously within neurons (established by chimeric larvae analysis) to regulate sodium channel clustering at nodes of Ranvier. Loss of ndrg4 sharply decreases expression of snap25 and nsf, implicating ndrg4 in control of vesicle exocytosis via the t-SNARE/NSF machinery.\",\n      \"method\": \"Zebrafish ndrg4 mutants, chimeric larvae analysis, in situ hybridization, immunofluorescence, molecular analysis of snap25/nsf expression\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-autonomous function established by chimeric analysis, mechanistic pathway identified via molecular markers, published in peer-reviewed genetics journal\",\n      \"pmids\": [\"27902705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NDRG4 is expressed exclusively in neurons (not glia) throughout the body including the enteric nervous system, colocalizing with HuC/D (pan-neuronal marker) but not GFAP (enteric glial marker), as established by immunohistochemistry, Western blot, in situ mRNA hybridization, and confocal immunofluorescence on wild-type vs. knockout mouse tissues.\",\n      \"method\": \"Immunohistochemistry, Western blot, in situ mRNA hybridization, immunofluorescence/confocal microscopy, NDRG4 knockout mouse validation\",\n      \"journal\": \"Neurogastroenterology and motility\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods with genetic control (KO mice), cell-type specificity rigorously established\",\n      \"pmids\": [\"28524415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NDRG4 promotes myogenic differentiation by binding to CTMP (carboxyl-terminal modulator protein), thereby reducing the CTMP-Akt interaction, increasing Akt phosphorylation, and activating CREB, which drives expression of MyoD, myogenin, and myosin heavy chain.\",\n      \"method\": \"Gain/loss-of-function in C2C12 cells, co-immunoprecipitation (NDRG4-CTMP interaction), Western blot (p-Akt, p-CREB), myotube formation assay, qRT-PCR\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP interaction plus downstream pathway readouts and functional phenotype, single lab\",\n      \"pmids\": [\"29254199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NDRG4 interacts with p53 (confirmed by co-IP and immunofluorescence) and inhibits p53 expression and p53-mediated mitochondrial apoptosis signaling in cerebral ischemia/reperfusion injury. NDRG4 overexpression decreases infarct size; conversely, p53 in turn inhibits NDRG4 expression after I/R injury, creating a regulatory feedback.\",\n      \"method\": \"MCAO rat model, adenoviral overexpression, co-immunoprecipitation, immunofluorescence, Western blot, infarct size measurement\",\n      \"journal\": \"Brain research bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein interaction shown by Co-IP, functional consequence demonstrated in vivo, single lab\",\n      \"pmids\": [\"30593880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Epigenetic silencing of NDRG4 via promoter hypermethylation in breast cancer cells promotes integrin signaling: NDRG4 downregulation assembles β1-integrins into large punctate clusters at the leading edge of tumor cells, causing decreased adhesion to fibronectin and increased adhesion and migration towards vitronectin, facilitating lymph node metastasis.\",\n      \"method\": \"Stable knockdown, integrin clustering assay (immunofluorescence), adhesion/migration assays to fibronectin and vitronectin, methylation analysis, clinical cohort correlation\",\n      \"journal\": \"NPJ breast cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mechanism (integrin reorganization) linked to loss-of-function with multiple assays, single lab\",\n      \"pmids\": [\"30963110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-218-5p directly targets NDRG4 (validated by luciferase reporter assay). In OGD/R-injured PC12 cells, miR-218-5p inhibition upregulates NDRG4 and reduces inflammatory cytokines, oxidative stress, and apoptosis; NDRG4 silencing abolishes these protective effects, placing NDRG4 as a functional downstream target of miR-218-5p.\",\n      \"method\": \"Luciferase reporter assay, miRNA inhibitor transfection, siRNA knockdown, flow cytometry, Western blot, OGD/R model\",\n      \"journal\": \"Medical science monitor\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct miRNA-target interaction validated by reporter assay with epistasis rescue experiment, single lab\",\n      \"pmids\": [\"32048632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-433 directly targets NDRG4 (validated by dual-luciferase reporter assay and Western blot). miR-433 inhibition activates the PI3K/Akt pathway and protects against hypoxia/reoxygenation injury in H9c2 cardiomyocytes; NDRG4 silencing reverses these protective effects, placing NDRG4 as an effector of miR-433 in the PI3K/Akt pathway during myocardial I/R injury.\",\n      \"method\": \"Dual-luciferase reporter assay, Western blot, miRNA mimic/inhibitor transfection, siRNA knockdown, flow cytometry, in vivo rat IR model with antagomiR\",\n      \"journal\": \"Shock\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct miRNA-target validated by reporter assay, epistasis by NDRG4 knockdown rescue, in vivo confirmation, single lab\",\n      \"pmids\": [\"32187107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of Ndrg4 in enteric neurons is associated with enlarged intestinal adenoma development. Ndrg4-/- enteric nervous system cell secretome, enriched for Nidogen-1 (Nid1) and Fibulin-2 (Fbln2), boosts organoid growth and enhances CRC cell migration, linking NDRG4 in enteric neurons to paracrine regulation of colorectal carcinogenesis.\",\n      \"method\": \"Ndrg4 knockout mouse CRC models, indirect co-culture of ENS cells and intestinal organoids, quantitative proteomics of secretome, migration assay, in vivo adenoma models\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — combined in vivo, in vitro, and quantitative proteomics with mechanistic identification of secreted effectors (Nid1, Fbln2), rigorous use of KO models\",\n      \"pmids\": [\"33890711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NDRG4 sensitizes colorectal cancer cells to 5-FU by upregulating DDIT3 (CHOP) expression. NDRG4 inhibits PI3K/AKT and ERK signaling, promotes 5-FU-induced apoptosis, and this proapoptotic effect is dependent on DDIT3.\",\n      \"method\": \"Stable overexpression, cell proliferation assay, Western blot (PI3K/AKT, ERK), DDIT3 knockdown rescue experiment, apoptosis assay\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway inhibition shown plus epistasis via DDIT3 knockdown, single lab\",\n      \"pmids\": [\"34594423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A missense variant p.T256M in NDRG4 impairs proliferation of human cardiac myocytes (hCM) and causes G1 and G2 cell cycle arrest with increased p27 and caspase-9 expression, providing evidence that this variant is pathogenic in pulmonary atresia with ventricular septal defect and tetralogy of Fallot.\",\n      \"method\": \"Patient exome sequencing, functional assay in hCM (proliferation, cell cycle analysis, Western blot for p27 and caspase-9)\",\n      \"journal\": \"FEBS open bio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — variant functional characterization in human cells with defined molecular readouts, single study\",\n      \"pmids\": [\"33211401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NDRG4 overexpression in esophageal adenocarcinoma cells downregulates Cyclin D1, CDK4, and CDK6 protein levels and inhibits tumor cell growth in 2D and 3D organotypic culture models, implicating NDRG4 in cell cycle regulation through CDK/Cyclin pathways.\",\n      \"method\": \"Stable overexpression, Western blot (Cyclin D1, CDK4, CDK6), 2D/3D organotypic growth assay, EdU proliferation assay\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays with defined molecular targets, single lab\",\n      \"pmids\": [\"32927604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NDRG4 overexpression in pancreatic ductal adenocarcinoma cells attenuates mitochondrial function: reduces ATP production, decreases mitochondrial membrane potential, and increases mitochondrial fragmentation. NDRG4 knockdown in normal pancreatic cells produces opposite effects, establishing a direct role for NDRG4 in mitochondrial regulation.\",\n      \"method\": \"Stable overexpression and knockdown, ATP production assay, mitochondrial membrane potential assay, mitochondrial morphology analysis\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain and loss of function with multiple mitochondrial readouts, single lab\",\n      \"pmids\": [\"33298240\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDRG4 is a neuron-specific (and cardiomyocyte-expressed) member of the NDRG family that localizes to mitochondria and ER; it acts downstream of TBX5 during cardiac development to support cardiomyocyte proliferation, functions within neurons to regulate vesicle exocytosis (via snap25/NSF) and sodium channel clustering at nodes of Ranvier, maintains brain BDNF levels, promotes neurite outgrowth and NGF-MEK/ERK signaling (while attenuating nuclear Elk-1 activation via microtubules), physically interacts with CTMP to activate the Akt/CREB axis for myogenesis, physically interacts with p53 to suppress p53-mediated mitochondrial apoptosis, physically interacts with Bves to direct fibronectin recycling endosome fusion for directional epithelial migration, modulates integrin clustering and cell adhesion to regulate metastatic behavior, and is epigenetically silenced by promoter hypermethylation in multiple cancers where its loss promotes tumor cell proliferation, invasion, and—in the enteric nervous system—paracrine secretion of Nid1/Fbln2 that drives colorectal carcinogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NDRG4 is a neuron- and cardiomyocyte-enriched cytoplasmic protein that couples intracellular signaling and vesicle trafficking to control cell proliferation, differentiation, migration, and survival across neural, cardiac, and epithelial tissues [#4, #7, #11]. In neurons it functions cell-autonomously to support sodium channel clustering at nodes of Ranvier and to maintain expression of the exocytic machinery snap25 and nsf, and is required for normal NGF-induced neurite outgrowth and downstream AP-1 and MEK/ERK signaling, while uncoupling ERK from nuclear Elk-1 activation in a microtubule-dependent manner [#11, #2, #3]. NDRG4-deficient mice show selectively reduced brain BDNF, impaired spatial learning, and enlarged ischemic infarcts, establishing a neuroprotective role [#7]. During cardiac development NDRG4 acts downstream of tbx5 to drive cardiomyocyte proliferation and proper heart morphogenesis [#4]. NDRG4 executes its cellular roles through defined physical partners: it binds Bves to direct fibronectin recycling-endosome fusion required for directional epithelial migration [#9], binds CTMP to relieve CTMP inhibition of Akt and thereby activate CREB-driven myogenic differentiation [#13], and binds p53 to restrain p53-mediated mitochondrial apoptosis [#10, #14]. NDRG4 is epigenetically silenced by promoter hypermethylation in colorectal, breast, and other cancers, where it normally suppresses proliferation, invasion, and metastasis—acting through cell-cycle control (cyclin D1/p27, CDK4/6), integrin clustering and adhesion, and, in the enteric nervous system, by limiting paracrine secretion of Nid1/Fbln2 that drives colorectal carcinogenesis [#6, #15, #21, #18]. A pathogenic missense variant (p.T256M) impairing cardiomyocyte proliferation links NDRG4 to pulmonary atresia with ventricular septal defect and tetralogy of Fallot [#20].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Establishing where NDRG4 is expressed was the prerequisite for any functional model; isoform mapping showed brain- and heart-restricted expression localized to neurons.\",\n      \"evidence\": \"Northern/Western blot, in situ hybridization and cDNA cloning of three splice isoforms\",\n      \"pmids\": [\"11352569\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Isoform-specific functions not resolved\", \"No subcellular localization defined at this stage\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Subcellular fractionation answered where NDRG4 acts within the cell, placing it at mitochondria and as a membrane-associated, luminally oriented ER protein.\",\n      \"evidence\": \"Subcellular fractionation with detergent solubility and protease susceptibility assays in rat brain\",\n      \"pmids\": [\"11978392\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Membrane topology determinants unknown\", \"Functional consequence of ER/mitochondrial localization not tested here\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Loss- and gain-of-function in PC12 cells linked NDRG4 levels to NGF-driven neurite outgrowth and AP-1 activation, giving it a role in neuronal differentiation signaling.\",\n      \"evidence\": \"Antisense and overexpression PC12 clones, neurite measurement, AP-1 reporter assay\",\n      \"pmids\": [\"11978393\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism connecting NDRG4 to AP-1 not defined\", \"No direct binding partner identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Pharmacological dissection refined the signaling role, showing NDRG4 enhances NGF-induced MEK/ERK phosphorylation yet attenuates nuclear Elk-1 activation via microtubules.\",\n      \"evidence\": \"Stable overexpression in PC12 cells, phospho-Western, Elk-1/SRE reporter, colchicine vs cytochalasin D\",\n      \"pmids\": [\"16408304\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of microtubule involvement unresolved\", \"No direct ERK-pathway interactor shown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Zebrafish knockdown placed NDRG4 in cardiac development downstream of tbx5, answering whether its heart expression is functionally required for cardiomyocyte proliferation.\",\n      \"evidence\": \"Morpholino knockdown, in situ hybridization, tbx5/tbx20 genetic epistasis, histology\",\n      \"pmids\": [\"18407257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional link from tbx5 to ndrg4 not shown\", \"Effector mediating proliferation downstream of ndrg4 unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Parallel cancer studies established opposing context-dependent roles: NDRG4 is required for GBM survival but is a methylation-silenced tumor suppressor in colorectal cancer.\",\n      \"evidence\": \"siRNA knockdown with cell-cycle/apoptosis readouts and xenografts (GBM); overexpression assays plus methylation-specific PCR in CRC cohorts\",\n      \"pmids\": [\"19592488\", \"19535783\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Basis of tissue-specific oncogenic vs suppressive role unexplained\", \"Direct targets of cell-cycle regulation not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The knockout mouse answered NDRG4's organismal neural function, showing it maintains brain BDNF, supports learning and memory, and protects against ischemic injury.\",\n      \"evidence\": \"Ndrg4 knockout mice, immunochemical neurotrophin profiling, Morris water maze, MCAO ischemia model\",\n      \"pmids\": [\"21636852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which NDRG4 maintains BDNF unresolved\", \"Cell type responsible for protection not pinpointed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of the Bves interaction provided the first direct molecular mechanism, linking NDRG4 to fibronectin recycling-endosome fusion and directional migration.\",\n      \"evidence\": \"Protein interaction mapping, fibronectin recycling assay, TIRF microscopy, directional migration assay\",\n      \"pmids\": [\"24048452\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Bves/NDRG4 interaction unknown\", \"Generality across cell types untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Co-IP demonstrated NDRG4 binds p53 and restrains p53-mediated mitochondrial apoptosis, explaining the pro-survival side of its cancer phenotype.\",\n      \"evidence\": \"siRNA knockdown, Annexin-V/JC-1 assays, immunoprecipitation, PFT-α inhibition in meningioma cells\",\n      \"pmids\": [\"26053091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding interface not mapped\", \"Single cell-type context\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Cell-autonomous zebrafish analysis defined a neuronal mechanism: NDRG4 controls node-of-Ranvier sodium channel clustering and the snap25/nsf exocytic machinery.\",\n      \"evidence\": \"ndrg4 mutant and chimeric larvae, in situ hybridization, immunofluorescence, snap25/nsf expression analysis\",\n      \"pmids\": [\"27902705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NDRG4 regulates snap25/nsf transcription unknown\", \"Direct involvement in vesicle fusion not biochemically shown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Rigorous cell-type mapping established that NDRG4 is exclusively neuronal, including the enteric nervous system, refining all downstream interpretation.\",\n      \"evidence\": \"Immunohistochemistry, in situ hybridization, confocal immunofluorescence with HuC/D and GFAP markers, KO mouse validation\",\n      \"pmids\": [\"28524415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subtype specificity within neurons not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The CTMP interaction explained how NDRG4 activates Akt/CREB signaling to promote myogenic differentiation.\",\n      \"evidence\": \"C2C12 gain/loss-of-function, co-IP of NDRG4-CTMP, phospho-Akt/CREB Western, myotube and qRT-PCR assays\",\n      \"pmids\": [\"29254199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CTMP regulation operates in neural/cardiac contexts untested\", \"Binding interface not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cancer mechanism studies expanded NDRG4's suppressive repertoire to integrin reorganization, CDK/Cyclin control, and mitochondrial function across breast, esophageal, and pancreatic models.\",\n      \"evidence\": \"Knockdown/overexpression with integrin clustering and adhesion assays, CDK4/6/Cyclin D1 Western, mitochondrial ATP/membrane-potential/morphology assays\",\n      \"pmids\": [\"30963110\", \"32927604\", \"33298240\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular partners for integrin and mitochondrial effects not identified\", \"Single-lab findings per tumor type\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"miRNA studies positioned NDRG4 as a regulated downstream effector in ischemia/reperfusion injury, with miR-218-5p and miR-433 directly targeting it.\",\n      \"evidence\": \"Luciferase reporter validation, miRNA mimic/inhibitor and siRNA rescue in OGD/R PC12 and H9c2 cells, in vivo IR models\",\n      \"pmids\": [\"32048632\", \"32187107\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NDRG4 itself drives PI3K/Akt protection mechanistically unresolved\", \"Physiological miRNA-NDRG4 axis in vivo not fully established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Combined in vivo and proteomic work showed enteric-neuronal NDRG4 loss drives colorectal carcinogenesis through paracrine secretion of Nid1/Fbln2, and a separate study linked NDRG4 to 5-FU chemosensitivity via DDIT3.\",\n      \"evidence\": \"Ndrg4 KO CRC mouse models, ENS-organoid co-culture, secretome proteomics; overexpression with DDIT3 knockdown rescue and apoptosis assays\",\n      \"pmids\": [\"33890711\", \"34594423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How neuronal NDRG4 loss controls Nid1/Fbln2 secretion mechanistically unknown\", \"Receptor on tumor cells for paracrine signal not identified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Functional characterization of a patient missense variant provided direct evidence linking NDRG4 to congenital heart disease.\",\n      \"evidence\": \"Exome sequencing and p.T256M functional assays in human cardiac myocytes (proliferation, cell cycle, p27/caspase-9 Western)\",\n      \"pmids\": [\"33211401\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant in limited patient set\", \"Mechanism by which T256M impairs proliferation not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The biochemical activity of NDRG4 itself—whether it has intrinsic catalytic, scaffolding, or adaptor function that unifies its diverse interactions with Bves, CTMP, and p53—remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No defined enzymatic or biochemical activity\", \"No structural model linking partner interactions\", \"Mechanism unifying neuronal, cardiac, and tumor-suppressive roles unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [9, 13, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1, 22]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 18, 15]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [10, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 13]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BVES\", \"CTMP\", \"TP53\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}